Medical News

RSS

US Oncology introduces new KnowMed Technology Platform to support oncologists nationwide

US Oncology, Inc., the nation's leading integrated oncology company, today announced its new iKnowMed™ Technology Platform to support community oncologists nationwide. This new platform enhances cancer care quality and practice efficiency through integrated, oncology-specific technologies that enable community oncologists to solve challenges in the areas of care delivery, drug management, and revenue cycle management.

2 Jun 2010

Allos Therapeutics' FOLOTYN data to be presented at 46th ASCO and 15th EHA Congress

Allos Therapeutics, Inc. today announced that data on FOLOTYN® (pralatrexate injection) will be presented at two upcoming medical conferences: the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO), which will be held June 4-8 in Chicago, Illinois, and at the 15th Congress of the European Hematology Association (EHA), which will be held June 10-13 in Barcelona, Spain.

2 Jun 2010

TapImmune signs Licensing Option agreement with Mayo Clinic for breast cancer vaccine technology

TapImmune Inc. announced that it has signed an exclusive Licensing Option agreement with Mayo Clinic, Rochester, MN, for clinical development of a breast cancer vaccine technology. The option to license this technology can be exercised after Phase I clinical trials under terms agreed between Mayo Clinic and TapImmune.

2 Jun 2010

Medtronic discloses payments, mostly royalties, to doctors

The Wall Street Journal: "Medical-device maker Medtronic Inc. disclosed that it made payments of more than $15.7 million in royalties and consulting fees to U.S. doctors in the first quarter, the first time the big Minneapolis company has provided such details. In making the voluntary disclosure, Medtronic is stepping ahead of requirements of a new federal law mandating such publication by 2013.

2 Jun 2010

FDA grants priority review status to Eisai's eribulin NDA

Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted priority review status to the company's New Drug Application (NDA) for the investigational agent eribulin mesylate ("eribulin," also known as E7389). Eisai is seeking FDA approval for eribulin in the treatment of patients with locally advanced or metastatic breast cancer previously treated with at least two chemotherapy regimens, including an anthracycline and a taxane.

2 Jun 2010

New study provides further evidence of link between indoor tanning and melanoma

A new study has provided further evidence of a link between indoor tanning and melanoma, the deadliest form of skin cancer. Scientists at the University of Minnesota's School of Public Health and Masonic Cancer Centre claim that their study, which is published in the journal Cancer Epidemiology, Biomarkers and Prevention, "definitively links" the use of sunbeds to melanoma.

2 Jun 2010

Generex awarded new patents in Japan and Ukraine for buccal drug delivery platform technologies

Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has been awarded two new patents in Japan and Ukraine.

2 Jun 2010

With Congress on recess, health reform politics emerge on homefront

While Americans remain divided over the new health reform law, "they aren't clamoring for its repeal. … Instead, the public seems willing to listen to candidates who would give the overhaul a chance and fix or improve it as needed. That's the signal from some surveys and a congressional race in a bellwether Pennsylvania district."

2 Jun 2010

Latinos have highest rates of eye disease: New research

New research suggests Latinos have the highest rates of eye disease in the United States, and one Los Angeles area clinic, Eye Physicians of Long Beach, is supremely prepared to meet the community's eye care needs.

2 Jun 2010

Cognitive ability makes the difference in decision-making

Just because your mother has turned 85, you shouldn't assume you'll have to take over her financial matters. She may be just as good or better than you at making quick, sound, money-making decisions, according to researchers at Duke University.

2 Jun 2010

Prototype breast cancer vaccine shows promising results in mice

US scientists have developed a prototype breast cancer vaccine that has shown promising results in very early laboratory tests on mice. The vaccine contains a protein called alpha-lactalbumin, which is found in large quantities in the majority of breast cancers.

2 Jun 2010

Parents can play critical role in children's autism treatment: New research

New research on behavioral treatment for autism has been released by the Chicago Children's Clinic, advancing previous findings that parents can play a critical role in a child's autism treatment.

2 Jun 2010

Former Columbia/HCA CEO Rick Scott spends millions on Florida governor campaign

News outlets report on the campaign of multimillionaire Rick Scott, the former CEO of the Columbia/HCA health care company, who is running in the Republican gubernatorial primary in Florida.

2 Jun 2010

Scammers look to take advantage of health law

The Green Bay CBS affiliate is reporting that the "Better Business Bureau is putting out an alert about health insurance related scams." Scammers have been more active since the health bill passed.

2 Jun 2010

Tomorrow's elderly will need to pay for care

As their autonomy fades, tomorrow's elderly will need to create non-traditional support networks or pay for the care they receive.

2 Jun 2010

McGill University granted 'Orphan Drug Designation' for pulmonary infection drug fenretinide

In addition to their suffering, rare disease patients often have to face the harsh reality that few pharmaceutical companies will ever be able to offer new treatments for their condition because the costs of new treatments will never be recovered from such a small market. But there are ways they can be helped. The U.S. Food and Drug Administration's "Orphan Drug Designation" offers a wide range of benefits that help organizations developing treatments for diseases and conditions affecting fewer than 200,000 patients in the United States.

2 Jun 2010

New report shows one in three young women receive HPV vaccine to prevent cervical cancer

Only about one in three young women has received the human papillomavirus vaccine to help prevent cervical cancer, according to a new report from researchers at Washington University School of Medicine in St. Louis.

2 Jun 2010

Cancer patients should find ways to be physically active during and after treatment: New national guidelines

Cancer patients who've been told to rest and avoid exercise can - and should - find ways to be physically active both during and after treatment, according to new national guidelines. Kathryn Schmitz, PhD, MPH, an associate professor of Epidemiology and Biostatistics and a member of the Abramson Cancer Center at the University of Pennsylvania School of Medicine, will present these guidelines at an educational session at the 2010 meeting of the American Society of Clinical Oncology, aimed at making cancer exercise rehabilitation programs as common as those offered to people who have had heart attacks or undergone cardiac surgery.

2 Jun 2010

Scientists discover key mechanism of cancer cells

Many tumor cells would not be viable due to aberrant chromosome distribution if they had not developed a special trick. Scientists from the German Cancer Research Center have investigated which genes are responsible for this survival strategy of cancer cells.

2 Jun 2010

Onyx Pharmaceuticals commences Phase 1 study of ONX 0912 oral proteasome inhibitor for cancer

Onyx Pharmaceuticals, Inc. today announced the initiation of a Phase 1 study of ONX 0912, an oral proteasome inhibitor, in patients with advanced refractory or recurrent solid tumors.

2 Jun 2010

Medical News

US Oncology introduces new KnowMed Technology Platform to support oncologists nationwide

Allos Therapeutics' FOLOTYN data to be presented at 46th ASCO and 15th EHA Congress

TapImmune signs Licensing Option agreement with Mayo Clinic for breast cancer vaccine technology

Medtronic discloses payments, mostly royalties, to doctors

FDA grants priority review status to Eisai's eribulin NDA

New study provides further evidence of link between indoor tanning and melanoma

Generex awarded new patents in Japan and Ukraine for buccal drug delivery platform technologies

With Congress on recess, health reform politics emerge on homefront

Latinos have highest rates of eye disease: New research

Cognitive ability makes the difference in decision-making

Prototype breast cancer vaccine shows promising results in mice

Parents can play critical role in children's autism treatment: New research

Former Columbia/HCA CEO Rick Scott spends millions on Florida governor campaign

Scammers look to take advantage of health law

Tomorrow's elderly will need to pay for care

McGill University granted 'Orphan Drug Designation' for pulmonary infection drug fenretinide

New report shows one in three young women receive HPV vaccine to prevent cervical cancer

Cancer patients should find ways to be physically active during and after treatment: New national guidelines

Scientists discover key mechanism of cancer cells

Onyx Pharmaceuticals commences Phase 1 study of ONX 0912 oral proteasome inhibitor for cancer

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News